Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Organization National Institutes of HealthPosted 31 Oct 2024Deadline 2 Jun 2027
HHS-NIH1193.39393.12193.21393.31393.866synopsis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Opportunity Number: PAR-25-211 Document Type: synopsis CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →